Profile
Gregory T.
Bates worked as Senior VP-Regulatory Affairs & Quality at XenoPort, Inc. He then worked as Vice President-Regulatory Affairs at ATAI Life Sciences NV from 2019 to 2022.
Bates received his undergraduate degree from the University of California, Berkeley and his doctorate degree from the University of California, Davis.
Former positions of Gregory T. Bates
| Companies | Position | End |
|---|---|---|
| ATAI LIFE SCIENCES N.V. | General Counsel | 2022-04-30 |
| XENOPORT, INC. | General Counsel | - |
Training of Gregory T. Bates
| University of California, Berkeley | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ATAI LIFE SCIENCES N.V. | Health Technology |
| Private companies | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Stock Market
- Insiders
- Gregory T. Bates
